These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 35168239)
21. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease. Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831 [TBL] [Abstract][Full Text] [Related]
22. Initial butyrate producers during infant gut microbiota development are endospore formers. Appert O; Garcia AR; Frei R; Roduit C; Constancias F; Neuzil-Bunesova V; Ferstl R; Zhang J; Akdis C; Lauener R; Lacroix C; Schwab C Environ Microbiol; 2020 Sep; 22(9):3909-3921. PubMed ID: 32686173 [TBL] [Abstract][Full Text] [Related]
23. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. Van den Abbeele P; Belzer C; Goossens M; Kleerebezem M; De Vos WM; Thas O; De Weirdt R; Kerckhof FM; Van de Wiele T ISME J; 2013 May; 7(5):949-61. PubMed ID: 23235287 [TBL] [Abstract][Full Text] [Related]
24. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Duncan SH; Barcenilla A; Stewart CS; Pryde SE; Flint HJ Appl Environ Microbiol; 2002 Oct; 68(10):5186-90. PubMed ID: 12324374 [TBL] [Abstract][Full Text] [Related]
25. Intestinal Microbiota in Patients with Spinal Cord Injury. Gungor B; Adiguzel E; Gursel I; Yilmaz B; Gursel M PLoS One; 2016; 11(1):e0145878. PubMed ID: 26752409 [TBL] [Abstract][Full Text] [Related]
26. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Thibault R; Blachier F; Darcy-Vrillon B; de Coppet P; Bourreille A; Segain JP Inflamm Bowel Dis; 2010 Apr; 16(4):684-95. PubMed ID: 19774643 [TBL] [Abstract][Full Text] [Related]
28. Increased Ponziani FR; Scaldaferri F; De Siena M; Mangiola F; Matteo MV; Pecere S; Petito V; Sterbini FP; Lopetuso LR; Masucci L; Cammarota G; Sanguinetti M; Gasbarrini A Benef Microbes; 2020 Oct; 11(6):519-525. PubMed ID: 32885687 [TBL] [Abstract][Full Text] [Related]
29. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis. Yamada T; Hino S; Iijima H; Genda T; Aoki R; Nagata R; Han KH; Hirota M; Kinashi Y; Oguchi H; Suda W; Furusawa Y; Fujimura Y; Kunisawa J; Hattori M; Fukushima M; Morita T; Hase K EBioMedicine; 2019 Oct; 48():513-525. PubMed ID: 31521614 [TBL] [Abstract][Full Text] [Related]
30. The association between gut butyrate-producing bacteria and non-small-cell lung cancer. Gui Q; Li H; Wang A; Zhao X; Tan Z; Chen L; Xu K; Xiao C J Clin Lab Anal; 2020 Aug; 34(8):e23318. PubMed ID: 32227387 [TBL] [Abstract][Full Text] [Related]
31. Studies on the effect of system retention time on bacterial populations colonizing a three-stage continuous culture model of the human large gut using FISH techniques. Child MW; Kennedy A; Walker AW; Bahrami B; Macfarlane S; Macfarlane GT FEMS Microbiol Ecol; 2006 Feb; 55(2):299-310. PubMed ID: 16420637 [TBL] [Abstract][Full Text] [Related]
32. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. Balamurugan R; Rajendiran E; George S; Samuel GV; Ramakrishna BS J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1298-303. PubMed ID: 18624900 [TBL] [Abstract][Full Text] [Related]
33. Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Kasahara K; Krautkramer KA; Org E; Romano KA; Kerby RL; Vivas EI; Mehrabian M; Denu JM; Bäckhed F; Lusis AJ; Rey FE Nat Microbiol; 2018 Dec; 3(12):1461-1471. PubMed ID: 30397344 [TBL] [Abstract][Full Text] [Related]
34. Gut Microbiome-Induced Shift of Acetate to Butyrate Positively Manages Dysbiosis in High Fat Diet. Si X; Shang W; Zhou Z; Strappe P; Wang B; Bird A; Blanchard C Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29178599 [TBL] [Abstract][Full Text] [Related]
35. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. Ananthakrishnan AN; Luo C; Yajnik V; Khalili H; Garber JJ; Stevens BW; Cleland T; Xavier RJ Cell Host Microbe; 2017 May; 21(5):603-610.e3. PubMed ID: 28494241 [TBL] [Abstract][Full Text] [Related]
36. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. Kumari R; Ahuja V; Paul J World J Gastroenterol; 2013 Jun; 19(22):3404-14. PubMed ID: 23801832 [TBL] [Abstract][Full Text] [Related]
37. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa. Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052 [TBL] [Abstract][Full Text] [Related]
38. Alterations in the relative abundance of Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514 [No Abstract] [Full Text] [Related]